Preface |
|
xiii | |
Chapter 1 Review Of Basic Mathematical Principles |
|
1 | (30) |
|
|
2 | (2) |
|
|
4 | (1) |
|
|
5 | (3) |
|
|
8 | (2) |
|
|
10 | (2) |
|
|
12 | (3) |
|
|
15 | (1) |
|
|
15 | (6) |
|
1.9 Dimensional Analysis 18 |
|
|
|
|
21 | (10) |
Chapter 2 Systems Of Measurement |
|
31 | (23) |
|
|
31 | (1) |
|
|
32 | (1) |
|
|
33 | (1) |
|
2.3.1 The Avoirdupois System |
|
|
33 | (1) |
|
2.3.2 The Apothecary or Troy System |
|
|
33 | (1) |
|
2.4 Measurement of Weight |
|
|
33 | (5) |
|
|
33 | (2) |
|
|
35 | (1) |
|
2.4.2.1 Avoirdupois Weight |
|
|
35 | (1) |
|
2.4.2.2 Apothecary Weight |
|
|
36 | (1) |
|
2.4.3 Practical Weight Equivalents |
|
|
36 | (2) |
|
2.5 Measurement of Volume |
|
|
38 | (3) |
|
|
38 | (1) |
|
|
39 | (1) |
|
2.5.3 Practical Volume Equivalents |
|
|
39 | (2) |
|
2.6 Measurement of Length |
|
|
41 | (2) |
|
2.7 Intersystem Relationships |
|
|
43 | (6) |
|
2.8 Household Equivalents and Metric Estimation 44 |
|
|
|
|
49 | (5) |
Chapter 3 Prescriptions And Medication Orders |
|
54 | (49) |
|
3.1 Prescribing Authority |
|
|
55 | (2) |
|
|
57 | (1) |
|
3.3 Practices To Prevent Medication Errors |
|
|
58 | (2) |
|
|
60 | (9) |
|
3.5 Outpatient Prescription Drug Orders |
|
|
69 | (3) |
|
3.5.1 Prescriptions for Manufactured Drug Products |
|
|
69 | (1) |
|
3.5.2 Prescriptions for Compounded Drug Products |
|
|
69 | (35) |
|
3.5.2.1 Types of Compounded Orders |
|
|
70 | (40) |
|
3.5.2.2.1 Formulation Based on Total Quantity |
|
|
70 | (1) |
|
3.5.2.3.2 Formulation Based on Single Dosage Unit |
|
|
71 | (1) |
|
3.6 Inpatient Medication Orders |
|
|
72 | (5) |
|
|
77 | (1) |
|
3.8 Calculations To Check "DEA" Numbers |
|
|
77 | (3) |
|
3.9 Reducing and Enlarging Formulas |
|
|
80 | (10) |
|
|
|
|
90 | (13) |
Chapter 4 Weighing And Measuring In Pharmacy Practice |
|
103 | (57) |
|
|
103 | (1) |
|
|
104 | (4) |
|
4.2.1 Absolute Error: Indication of Error Based on Maximum Deviation and Significant Figures |
|
|
104 | (3) |
|
4.2.2 Relative Error: Indication of Error Based on Percentage of Estimated Value |
|
|
107 | (1) |
|
4.3 Tolerance In Prescription Compounding and Pharmaceutical Manufacturing |
|
|
108 | (1) |
|
4.4 Weighing and Measuring |
|
|
109 | (10) |
|
4.4.1 Electronic Balances |
|
|
109 | (1) |
|
4.4.2 Prescription Balances: Class A, Torsion |
|
|
110 | (4) |
|
4.4.2.1 Sensitivity Requirement (SR) |
|
|
110 | (1) |
|
4.4.2.2 Minimum Weighable Quantity (MWQ) or Least Weighable Quantity (LWQ) |
|
|
110 | (1) |
|
|
111 | (3) |
|
4.4.3 Volumetric Devices for Pharmaceutical Measurements |
|
|
114 | (5) |
|
4.4.3.1 The Meniscus and Effect of Viscosity |
|
|
114 | (1) |
|
|
114 | (1) |
|
4.4.3.3 Pipets (Pipettes) |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (3) |
|
4.5 Aliquot Method and Triturations |
|
|
119 | (23) |
|
4.5.1 Solid-Solid Aliquot Method |
|
|
119 | (3) |
|
4.5.2 Solid-Solid Triturations |
|
|
122 | (9) |
|
4.5.3 Liquid-Liquid Aliquots and Triturations |
|
|
131 | (5) |
|
4.5.4 Solid-Liquid Aliquots |
|
|
136 | (4) |
|
|
140 | (2) |
|
|
142 | (2) |
|
|
144 | (1) |
|
|
145 | (15) |
Chapter 5 Dosage Calculations |
|
160 | (43) |
|
5.1 Calculations Involving Dose, Size, Number of Doses, Amount Dispensed, and Quantity of a Specific Ingredient in a Dose |
|
|
161 | (8) |
|
5.2 Dosage Measured By Drops |
|
|
169 | (2) |
|
5.3 Dosage Based on Body Weight |
|
|
171 | (3) |
|
5.4 Dosage Based on Body Surface Area (BSA) |
|
|
174 | (7) |
|
5.5 Pediatric and Geriatric Dose Calculations |
|
|
181 | (3) |
|
5.6 Chemotherapy Dose Calculations |
|
|
184 | (3) |
|
|
187 | (16) |
Chapter 6 Drug Concentration Expressions |
|
203 | (54) |
|
|
204 | (1) |
|
6.2 Percentage Strength Expressions |
|
|
204 | (14) |
|
6.2.1 Percent Volume-in-Volume |
|
|
204 | (1) |
|
6.2.2 Percent Weight-in-Weight |
|
|
205 | (1) |
|
6.2.3 Percent Weight-in-Volume |
|
|
206 | (2) |
|
6.2.4 Default Rules for Percentage Expressions |
|
|
208 | (2) |
|
6.2.5 Prescriptions and Formulations with Ingredients Listed as Percentage |
|
|
210 | (5) |
|
6.2.6 Using Specific Gravity to Calculate the Exact Amount of Solvent in a Solution |
|
|
215 | (2) |
|
6.2.7 Converting % w/w into %w/v Using Specific Gravity |
|
|
217 | (1) |
|
6.3 Stock Solutions, Concentrates, and Triturations |
|
|
218 | (4) |
|
|
222 | (2) |
|
6.5 Ratio Strength Expressions |
|
|
224 | (6) |
|
6.5.1 Ratio Volume-in-Volume |
|
|
224 | (1) |
|
6.5.2 Ratio Weight-in-Volume |
|
|
225 | (1) |
|
6.5.3 Ratio Weight-in-Weight |
|
|
226 | (4) |
|
6.6 Other Pharmaceutical Expressions of Drug Concentration |
|
|
230 | (5) |
|
6.6.1 Milligrams Per Milliliter (mg/mL) |
|
|
230 | (1) |
|
6.6.2 Milligrams Percent (mg%) and Miligrams Per Deciliter (mg/dL) |
|
|
231 | (1) |
|
6.6.3 Parts Per Million (ppm) and Parts Per Billion (ppb) |
|
|
232 | (2) |
|
6.6.4 Millimols, Milliequivalents, and Milliosmols Per Unit of Volume |
|
|
234 | (1) |
|
|
235 | (22) |
Chapter 7 Dilution And Concentration |
|
257 | (53) |
|
7.1 Problem-Solving Methodologies |
|
|
258 | (33) |
|
7.1.1 Concentration Principle |
|
|
258 | (2) |
|
7.1.2 Mass Balance Equation |
|
|
260 | (8) |
|
7.1.2.1 Dilution of Powders or Solid Mixtures |
|
|
261 | (4) |
|
7.1.2.2 Mixing Different Strengths |
|
|
265 | (2) |
|
7.1.2.3 Modifying the Drug Concentration of a Prepared Product: Increasing Drug Concentration |
|
|
267 | (1) |
|
7.1.3 The CQ Equation: Concentration X Quantity |
|
|
268 | (7) |
|
7.1.3.1 Expanded CQ Equation |
|
|
272 | (3) |
|
7.1.4 Algebraic Calculations Using the Concentration Equation and the CQ Equation |
|
|
275 | (8) |
|
7.1.5 Alligation Alternate |
|
|
283 | (8) |
|
7.1.5.1 Use of Alligation When Combining More Than Two Products |
|
|
287 | (4) |
|
7.2 So, Which Method Should I Use? |
|
|
291 | (5) |
|
7.2.1 Stock Solutions Diluted by the Patient |
|
|
293 | (3) |
|
|
296 | (14) |
Chapter 8 Isotonicity |
|
310 | (30) |
|
|
310 | (2) |
|
8.2 Sodium Chloride Equivalent Values |
|
|
312 | (3) |
|
8.3 Isotonicity by the Sodium Chloride Equivalent Method |
|
|
315 | (4) |
|
8.3.1 Sodium Chloride Equivalent: Method 1 |
|
|
315 | (3) |
|
8.3.2 Sodium Chloride Equivalent: Method 2 |
|
|
318 | (1) |
|
8.4 Other Tonicity Agents |
|
|
319 | (2) |
|
8.5 Isotonicity When One Ingredient is Already Isotonic |
|
|
321 | (2) |
|
8.6 Isotonic Buffered Solutions |
|
|
323 | (3) |
|
8.6.1 Using the White-Vincent Method to Adjust Tonicity |
|
|
323 | (3) |
|
|
326 | (3) |
|
8.8 Determination of the Tonicity of a Solution (Hypotonic, Isotonic, or Hypertonic) |
|
|
329 | (1) |
|
|
330 | (10) |
Chapter 9 Dosage Calculations Of Electrolytes |
|
340 | (38) |
|
9.1 Molarity and Molality |
|
|
341 | (3) |
|
|
341 | (3) |
|
|
344 | (1) |
|
9.2 Electrolyte Dissociation, Valence, Equivalent, and Equivalent Weight |
|
|
344 | (3) |
|
9.3 Milliequivalents, mEq/mL, mEq/L |
|
|
347 | (7) |
|
9.3.1 Problem-Solving Methods for Milliequivalents |
|
|
348 | (6) |
|
9.4 Osmolarity (Osmolar Strength) |
|
|
354 | (12) |
|
9.4.1 Milliosmoles and mOsm/L |
|
|
355 | (11) |
|
|
366 | (12) |
Chapter 10 Calculations For Injectable Medications And Sterile Fluids |
|
378 | (35) |
|
10.1 Reconstitution of Dry Powders |
|
|
378 | (8) |
|
10.1.1 Reconstituting with Volumes Other Than Those on Manufacturer's Label |
|
|
380 | (3) |
|
10.1.2 Considering Powder Volume |
|
|
383 | (2) |
|
10.1.3 Powders as Compounding Sources of Drugs |
|
|
385 | (1) |
|
10.2 Calculations Related to Units/ml (Insulin, Heparin) and Other Units of Potency |
|
|
386 | (6) |
|
10.2.1 Calculations of Insulin Single Dose and Combinations |
|
|
387 | (4) |
|
10.2.2 Calculations of Heparin Doses |
|
|
391 | (1) |
|
10.3 Intravenous Admixtures |
|
|
392 | (3) |
|
10.4 Extemporaneous IV Fluids |
|
|
395 | (2) |
|
10.5 Flow Rates in Intravenous Sets |
|
|
397 | (2) |
|
|
399 | (14) |
Chapter 11 Enteral And Parenteral Nutrition |
|
413 | (45) |
|
11.1 Screening and Assessment of Nutritional Needs |
|
|
414 | (2) |
|
11.1.1 Body Mass Index (BMI), Waist Circumference, and Associated Disease Risks |
|
|
414 | (2) |
|
11.1.2 Assessment of Malnutrition |
|
|
416 | (1) |
|
|
416 | (2) |
|
11.3 Parenteral Nutrition (PN): 2-in-1 and 3-in-1 Formulations |
|
|
418 | (2) |
|
11.4 Calculation of Nutritional Requirements |
|
|
420 | (9) |
|
11.4.1 Caloric Requirement Equations |
|
|
420 | (5) |
|
|
425 | (1) |
|
11.4.3 Protein Requirement (Nitrogen) |
|
|
425 | (3) |
|
11.4.4 Carbohydrate and Fat Requirements |
|
|
428 | (1) |
|
11.4.5 Micronutrient Requirements (Electrolytes, Vitamins, and Trace Elements) |
|
|
428 | (1) |
|
11.5 Calculations for Compounding Parenteral Nutrition |
|
|
429 | (15) |
|
11.5.1 Calculation of Electrolytes |
|
|
430 | (3) |
|
11.5.2 Calculation of Carbohydrate and Fat |
|
|
433 | (2) |
|
11.5.3 Calculation of Protein |
|
|
435 | (3) |
|
11.5.4 Calculation of Other Additives |
|
|
438 | (6) |
|
11.6 Calculations Related to the Design of a PN |
|
|
444 | (2) |
|
|
446 | (12) |
Chapter 12 Miscellaneous Practical Calculations In Contemporary Compounding |
|
458 | (41) |
|
12.1 Compounding with Manufactured Dosage Forms |
|
|
459 | (6) |
|
12.1.1 Nonsterile Products |
|
|
460 | (3) |
|
|
463 | (2) |
|
12.2 Suppository Calculations |
|
|
465 | (1) |
|
12.2.1 Calibration of Molds |
|
|
465 | (1) |
|
12.3 Determination of Amount of Base/powder Occupied by the Drug(s): Solid Dosage Forms |
|
|
466 | (13) |
|
12.3.1 Density Factor Method |
|
|
467 | (7) |
|
12.3.2 Quantity/Volume of Base Occupied by Drug (or Density Ratio Method) |
|
|
474 | (1) |
|
12.3.3 Dosage Replacement Factor Method |
|
|
475 | (4) |
|
12.4 Lozenges and Lollipops |
|
|
479 | (1) |
|
12.4.1 Lozenge/Lollipop Mold Calibration |
|
|
479 | (1) |
|
12.5 Selecting a Capsule Size |
|
|
480 | (5) |
|
|
480 | (2) |
|
|
482 | (2) |
|
12.5.3 Volume Occupied by Active Ingredient in a Capsule |
|
|
484 | (1) |
|
12.6 Primary Emulsion Calculations (4:2:1 Ratio) |
|
|
485 | (2) |
|
12.7 A Little Touch of Veterinary Compounding |
|
|
487 | (2) |
|
|
489 | (10) |
Appendices |
|
499 | (30) |
|
Appendix 1 Systems Of Measurement |
|
|
500 | (2) |
|
Appendix 2 Chemical Elements And Atomic Weights |
|
|
502 | (1) |
|
Appendix 3 Calibration Of Medicinal Dropper |
|
|
503 | (1) |
|
Appendix 4 Solutions Used To Compound PN |
|
|
504 | (3) |
|
Appendix 5 Conversions: Temperature, Time, Proof Strength |
|
|
507 | (4) |
|
|
511 | (3) |
|
Appendix 7 Drug As A Base Versus Salt Or Ester |
|
|
514 | (3) |
|
Appendix 8 pH, Buffers, And Buffer Capacity |
|
|
517 | (8) |
|
Appendix 9 Normal Concentration |
|
|
525 | (2) |
|
Appendix 10 Biologics For Immunization |
|
|
527 | (2) |
Literature Consulted |
|
529 | (2) |
Index |
|
531 | |